XML 54 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2015
Fair Value Disclosures [Abstract]  
Liabilities Measured at Fair Value on a Recurring Basis
Liabilities Measured at Fair Value on a Recurring Basis as of December 31, 2015
 
Quoted Prices in
Active  Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable  Inputs
(Level 2)
 
Significant
Unobservable  Inputs
(Level 3)
 
Balance as of December 31, 2015
 
(in thousands)
Liabilities
 
 
 
 
 
 
 
Contingent obligation due selling unitholders of Cogent
$

 
$

 
$
13,647

 
$
13,647

Total
$

 
$

 
$
13,647

 
$
13,647


Changes in Level 3 Measured at Fair Value
Changes in Level 3 liabilities measured at fair value on a recurring basis for the year ended December 31, 2015 are as follows:
 
Opening Balance as of January 1, 2015
 
Total realized and unrealized gains (losses) included in Net Income
 
Unrealized gains (losses) included in Other Comprehensive Income
 
Purchases
 
Issues
 
Sales
 
Settlements
 
Closing Balance as of December 31, 2015
 
Unrealized gains (losses) for Level 3 liabilities outstanding at December 31, 2015
 
(in thousands)
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contingent obligation due selling unitholders of Cogent
$

 
$
(503
)
 
$

 
$
13,144

 
$

 
$

 
$

 
$
13,647

 
$
(503
)
Total
$

 
$
(503
)
 
$

 
$
13,144

 
$

 
$

 
$

 
$
13,647

 
$
(503
)
Quantitative Information
The following table presents quantitative information about the significant unobservable inputs utilized by the Company in the fair value measure of Level 3 liabilities measured at fair value on a recurring basis, as of December 31, 2015:
 
Fair Value as of December 31, 2015
 
Valuation Technique(s)
 
Unobservable  Input(s)
 
Range (Weighted Average)
 
(in thousands)
Liabilities
 
 
 
 
 
 
 
Contingent obligation due selling unitholders of Cogent
$
13,647

 
Present value of expected payments
 
Discount rate
 
12
%
 
 
 
 
 
Forecast revenue
(a)

 

_____________________________________________
(a) The Company's estimate of contingent consideration as of December 31, 2015 was principally based on the acquired business' projected revenue generation from April 1, 2015 through March 31, 2017 and April 1, 2017 through March 31, 2019.